Share-based Payment Arrangement, Expense of Bruker Cellular Analysis, Inc. from 31 Dec 2018 to 30 Jun 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bruker Cellular Analysis, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2018 to 30 Jun 2023.
  • Bruker Cellular Analysis, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2023 was $3,731,000, a 43% decline year-over-year.
  • Bruker Cellular Analysis, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Jun 2023 was $18,355,000, a 20% decline year-over-year.
  • Bruker Cellular Analysis, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $22,194,000, a 4.6% increase from 2021.
  • Bruker Cellular Analysis, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $21,222,000, a 94% increase from 2020.
  • Bruker Cellular Analysis, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $10,917,000, a 190% increase from 2019.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Bruker Cellular Analysis, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $18,355,000 $3,731,000 -$2,834,000 -43% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $21,189,000 $4,388,000 -$1,005,000 -19% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $22,194,000 $5,055,000 -$82,000 -1.6% 01 Oct 2022 31 Dec 2022 10-K 23 Feb 2023 2022 FY
Q3 2022 $22,276,000 $5,181,000 -$781,000 -13% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $23,057,000 $6,565,000 +$936,000 +17% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $22,121,000 $5,393,000 +$899,000 +20% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $21,222,000 $5,137,000 -$714,000 -12% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 $21,936,000 $5,962,000 +$3,427,000 +135% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $18,509,000 $5,629,000 +$4,277,000 +316% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $14,232,000 $4,494,000 +$3,315,000 +281% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $10,917,000 $5,851,000 01 Oct 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
Q3 2020 $2,535,000 +$1,543,000 +156% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $1,352,000 +$403,000 +42% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q1 2020 $1,179,000 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q3 2019 $992,000 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $949,000 01 Apr 2019 30 Jun 2019 10-Q 25 Aug 2020 2020 Q2

Bruker Cellular Analysis, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $22,194,000 +$972,000 +4.6% 01 Jan 2022 31 Dec 2022 10-K 23 Feb 2023 2022 FY
2021 $21,222,000 +$10,305,000 +94% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2023 2022 FY
2020 $10,917,000 +$7,157,000 +190% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 $3,760,000 +$1,774,000 +89% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $1,986,000 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.